ask="3.000"
ask_size="200"
average_daily_volume="187761"
bid="N/A"
bid_size="N/A"
book_value="0.563"
change="-0.031"
change_from_200_day_moving_average="0.242"
change_from_50_day_moving_average="0.128"
change_from_52_week_high="-1.201"
change_From_52_week_low="0.609"
change_in_percent="-1.148%"
close="2.669"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.308"
ebitda="-5.76M"
eps_estimate_current_year="-0.340"
eps_estimate_next_quarter="-0.210"
eps_estimate_next_year="-0.910"
ex_dividend_date="N/A"
float_shares="16233000"
high="2.696"
high_52_weeks="3.870"
last_trade_date="1/24/2017"
last_trade_price="2.669"
last_trade_size="300"
last_trade_time="3:58pm"
low="2.570"
low_52_weeks="2.060"
market_capitalization="49.88M"
moving_average_200_day="2.427"
moving_average_50_day="2.541"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.000"
open="2.680"
pe_ratio="N/A"
peg_ratio="0.000"
percent_change_from_200_day_moving_average="+9.981%"
percent_change_from_50_day_moving_average="+5.054%"
percent_change_from_52_week_high="-31.034%"
percent_change_from_52_week_low="+29.563%"
previous_close="2.700"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.796"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.380"
stock_exchange="NCM"
symbol="BCLI"
volume="103058"
weeks_range_52="2.060 - 3.870"
